首页 > 市场调查报告书 > 製药

药物开发开发业务受託机关

市场调查报告书

商品编码

1633877

全球孤儿药 CDMO 市场分析与预测（至 2033 年）：类型、产品、服务、技术、应用、最终用户、阶段、流程、形式和组件

Orphan Drugs CDMO Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Application, End User, Stage, Process, Mode, Component

出版日期: 2025年01月13日 | 出版商:

Global Insight Services | 英文 363 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球孤儿药 CDMO 市场预计将从 2023 年的 135 亿美元成长到 2033 年的 278 亿美元，复合年增长率为 7.4%。

孤儿药 CDMO 市场包括专门针对孤儿药（用于治疗罕见疾病的药物）的合约开发和製造服务。该市场包括解决罕见疾病药物开发的独特课题和监管要求的解决方案，包括配方、扩大规模、临床试验生产和商业化支援。

受罕见疾病发病率上升和有利的监管框架的推动，罕见疾病 CDMO 正在强劲扩张。生物製剂製造是表现最佳的子领域，这受到对先进疗法和个人化医疗日益增长的需求的推动。在技术进步和具有成本效益的製造解决方案的支持下，小分子药物製造表现排名第二。从地区来看，北美凭藉着完善的医疗基础设施、强大的研发能力以及政府的支持政策引领市场。欧洲是第二大最受青睐的地区，这得益于战略伙伴关係、创新激励以及对罕见疾病治疗日益增长的兴趣。亚太地区面积较小，但由于医疗保健条件改善、投资增加和製药业蓬勃发展，其发展势头强劲。这一充满活力的市场格局凸显了 CDMO 在解决未满足的医疗需求和推动罕见疾病药物开发创新方面发挥的关键作用。

2023年孤儿药CDMO市场预计将达到1.5亿单位，到2033年将达到2.5亿单位。生物製剂的市占率最高，为 45%，其次是小分子药物，为 30%，基因疗法为 25%。这一增长是由个人化医疗需求的不断增长和罕见疾病发病率的上升所推动的。市场的主要参与者包括 Lonza Group、Catalent 和 Thermo Fisher Scientific，每家都占有强大的市场占有率。Lonza Group 以其对先进生物製造技术的投资而闻名，而 Catalent 则专注于扩大其基因治疗能力。

竞争格局由策略联盟和合併塑造，而《孤儿药法案》和《市场条件条例》等监管框架则影响市场动态。这些法规透过提供市场独占权和税收抵免等激励措施对于促进创新至关重要。预计到 2033 年，受技术进步和监管环境改善的推动，研发投资将增加 15%。市场前景依然乐观，生物製剂和基因治疗领域存在巨大商机。然而，课题依然存在，包括高昂的开发成本和监管障碍。人工智慧和机器学习在药物开发过程中的融合有望开闢新的成长前景。

由于先进的医疗基础设施和对药物研究的大量投资，北美孤儿药 CDMO 市场正在蓬勃发展。美国在该地区处于领先地位，受益于强有力的监管框架和对罕见疾病的大量资金。这促进了创新并加速了药物开发过程。接下来是加拿大，该国政府的政策支持生技产业的蓬勃发展。

欧洲市场的特点是协作的监管环境和大量孤儿药开发资金。欧洲药品管理局在促进市场准入方面发挥着至关重要的作用。德国和法国等国家因其强大的製药业和对罕见疾病研究的重视而脱颖而出。

由于医疗保健支出的增加和对罕见疾病的认识的提高，亚太地区的孤儿药 CDMO 市场正在快速成长。中国和日本是领先的国家，由政府主导支持研发。该地区的生物技术产业正在扩大，进一步增强了其市场潜力。

以巴西和墨西哥为首的拉丁美洲呈现出良好的成长动能。这些国家正在投资本国医疗保健基础设施，并与全球製药公司建立合作关係。这提高了我们开发和生产罕见疾病药物的能力。

中东和非洲正逐渐成为罕见疾病CDMO市场的参与者。沙乌地阿拉伯和南非等国家正在投资医疗进步。在不断增长的需求和政府举措的推动下，这些国家正在建立支持罕见疾病治疗发展的能力。

概述
北美
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 法国
- 西班牙
- 义大利
- 荷兰
- 瑞典
- 瑞士
- 丹麦
- 芬兰
- 俄罗斯
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 澳洲
- 新加坡
- 印尼
- 台湾
- 马来西亚
- 其他亚太地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
中东/非洲
- 沙乌地阿拉伯
- 阿拉伯联合酋长国
- 南非
- 其他中东/非洲

第18章竞争格局

概述
市场占有率分析
大公司定位
竞争领导映射
供应商基准测试
对标发展策略

第19章公司简介

Lonza
Catalent
Samsung Biologics
WuXi Biologics
Boehringer Ingelheim BioXcellence
Fujifilm Diosynth Biotechnologies
AGC Biologics
Thermo Fisher Scientific
Recipharm
Piramal Pharma Solutions
Almac Group
Biocon
CordenPharma
Patheon
Ajinomoto Bio-Pharma Services
Abzena
Rentschler Biopharma
KBI Biopharma
Cambrex
Siegfried

简介目录

Product Code: GIS26276

The orphan drugs CDMO market is anticipated to expand from $13.5 billion in 2023 to $27.8 billion by 2033, reflecting a CAGR of 7.4%.

The Orphan Drugs CDMO market encompasses the specialized contract development and manufacturing services dedicated to orphan drugs, which are pharmaceutical agents developed to treat rare diseases. This market involves tailored solutions in drug formulation, scale-up, clinical trial production, and commercialization support, addressing the unique challenges and regulatory requirements of orphan drug development, thereby facilitating the availability of treatments for underserved patient populations.

The Orphan Drugs CDMO Market is witnessing robust expansion, driven by the rising prevalence of rare diseases and favorable regulatory frameworks. Biologics manufacturing emerges as the top-performing sub-segment, attributed to the increasing demand for advanced therapeutics and personalized medicine. Small molecule production follows as the second-highest performing sub-segment, supported by technological advancements and cost-effective manufacturing solutions. Regionally, North America leads the market, benefiting from well-established healthcare infrastructure, strong R&D capabilities, and supportive government policies. Europe stands as the second most lucrative region, propelled by strategic collaborations, innovation incentives, and a growing focus on rare disease treatment. The Asia-Pacific region, though smaller, is gaining momentum, driven by improving healthcare access, increasing investments, and a burgeoning pharmaceutical industry. This dynamic market landscape underscores the critical role of CDMOs in addressing unmet medical needs and fostering innovation in orphan drug development.

In 2023, the Orphan Drugs CDMO Market recorded a volume of 150 million units, with expectations to reach 250 million units by 2033. The biologics segment commands the largest market share at 45%, followed by small molecules at 30%, and gene therapies at 25%. This growth is driven by increasing demand for personalized medicine and the rising prevalence of rare diseases. Key players in the market include Lonza Group, Catalent, and Thermo Fisher Scientific, each maintaining a robust presence. Lonza Group is particularly noted for its investment in advanced biomanufacturing technologies, while Catalent focuses on expanding its gene therapy capabilities.

The competitive landscape is shaped by strategic collaborations and mergers, with regulatory frameworks such as the Orphan Drug Act and EMA Orphan Regulation influencing market dynamics. These regulations offer incentives, including market exclusivity and tax credits, which are crucial for driving innovation. The market outlook remains optimistic, with significant opportunities in biologics and gene therapies. However, challenges such as high development costs and regulatory hurdles persist. The integration of AI and machine learning in drug development processes is anticipated to unlock new growth prospects.

The North American orphan drugs CDMO market is robust, driven by advanced healthcare infrastructure and significant investments in pharmaceutical research. The United States leads this region, benefiting from a strong regulatory framework and substantial funding for rare diseases. This fosters innovation and accelerates drug development processes. Canada follows, with supportive government policies and growing biotech industry presence.

Europe's market is characterized by a collaborative regulatory environment and substantial funding for orphan drug development. The European Medicines Agency plays a pivotal role in facilitating market access. Countries like Germany and France are prominent due to their strong pharmaceutical sectors and emphasis on rare disease research.

Asia Pacific is experiencing rapid growth in the orphan drugs CDMO market, driven by increasing healthcare expenditure and rising awareness of rare diseases. China and Japan are key players, with government initiatives supporting research and development. The region's expanding biotechnology sector further enhances its market potential.

Latin America shows promising growth, with Brazil and Mexico leading the charge. These countries are investing in healthcare infrastructure and fostering partnerships with global pharmaceutical companies. This enhances their capacity to develop and manufacture orphan drugs.

The Middle East and Africa region is gradually emerging in the orphan drugs CDMO market. Countries like Saudi Arabia and South Africa are investing in healthcare advancements. They are building capabilities to support the development of treatments for rare diseases, driven by increasing demand and government initiatives.

Key Companies

Lonza, Catalent, Samsung Biologics, Wu Xi Biologics, Boehringer Ingelheim Bio Xcellence, Fujifilm Diosynth Biotechnologies, AGC Biologics, Thermo Fisher Scientific, Recipharm, Piramal Pharma Solutions, Almac Group, Biocon, Corden Pharma, Patheon, Ajinomoto Bio- Pharma Services, Abzena, Rentschler Biopharma, KBI Biopharma, Cambrex, Siegfried

Sources

U.S. Food and Drug Administration - Orphan Products Clinical Trials Grants Program, European Medicines Agency - Orphan Medicines, National Institutes of Health - Office of Rare Diseases Research, World Health Organization - Rare Diseases, International Rare Diseases Research Consortium, Orphanet - Portal for Rare Diseases and Orphan Drugs, National Organization for Rare Disorders, Genetic and Rare Diseases Information Center, European Organisation for Rare Diseases (EURORDIS), Global Genes, International Conference on Rare Diseases & Orphan Drugs, World Orphan Drug Congress, Rare Disease Day (EURORDIS Event), U.S. National Library of Medicine - PubMed, National Center for Advancing Translational Sciences, European Commission - Health and Food Safety, Biotechnology Innovation Organization, U.S. Department of Health & Human Services - Health Resources and Services Administration, International Society for Pharmaceutical Engineering, American Society of Gene & Cell Therapy

Research Scope

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

1: Orphan Drugs CDMO Market Overview

1.1 Objectives of the Study
1.2 Orphan Drugs CDMO Market Definition and Scope of the Report
1.3 Report Limitations
1.4 Years & Currency Considered in the Study
1.5 Research Methodologies
- 1.5.1 Secondary Research
- 1.5.2 Primary Research
- 1.5.3 Market Size Estimation: Top-Down Approach
- 1.5.4 Market Size Estimation: Bottom-Up Approach
- 1.5.5 Data Triangulation and Validation

2: Executive Summary

2.1 Summary
2.2 Key Opinion Leaders
2.3 Key Highlights of the Market, by Type
2.4 Key Highlights of the Market, by Product
2.5 Key Highlights of the Market, by Services
2.6 Key Highlights of the Market, by Technology
2.7 Key Highlights of the Market, by Application
2.8 Key Highlights of the Market, by End User
2.9 Key Highlights of the Market, by Stage
2.10 Key Highlights of the Market, by Process
2.11 Key Highlights of the Market, by Mode
2.12 Key Highlights of the Market, by Component
2.13 Key Highlights of the Market, by North America
2.14 Key Highlights of the Market, by Europe
2.15 Key Highlights of the Market, by Asia-Pacific
2.16 Key Highlights of the Market, by Latin America
2.17 Key Highlights of the Market, by Middle East
2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

3.1 Market Attractiveness Analysis, by Region
3.2 Market Attractiveness Analysis, by Type
3.3 Market Attractiveness Analysis, by Product
3.4 Market Attractiveness Analysis, by Services
3.5 Market Attractiveness Analysis, by Technology
3.6 Market Attractiveness Analysis, by Application
3.7 Market Attractiveness Analysis, by End User
3.8 Market Attractiveness Analysis, by Stage
3.9 Market Attractiveness Analysis, by Process
3.10 Market Attractiveness Analysis, by Mode
3.11 Market Attractiveness Analysis, by Component
3.12 Market Attractiveness Analysis, by North America
3.13 Market Attractiveness Analysis, by Europe
3.14 Market Attractiveness Analysis, by Asia-Pacific
3.15 Market Attractiveness Analysis, by Latin America
3.16 Market Attractiveness Analysis, by Middle East
3.17 Market Attractiveness Analysis, by Africa

4: Orphan Drugs CDMO Market Outlook

4.1 Orphan Drugs CDMO Market Segmentation
4.2 Market Dynamics
- 4.2.1 Market Drivers
- 4.2.2 Market Trends
- 4.2.3 Market Restraints
- 4.2.4 Market Opportunities
4.3 Porters Five Forces Analysis
- 4.3.1 Threat of New Entrants
- 4.3.2 Threat of Substitutes
- 4.3.3 Bargaining Power of Buyers
- 4.3.4 Bargaining Power of Supplier
- 4.3.5 Competitive Rivalry
4.4 PESTLE Analysis
4.5 Value Chain Analysis
4.6 4Ps Model
4.7 ANSOFF Matrix

5: Orphan Drugs CDMO Market Strategy

5.1 Parent Market Analysis
5.2 Supply-Demand Analysis
5.3 Consumer Buying Interest
5.4 Case Study Analysis
5.5 Pricing Analysis
5.6 Regulatory Landscape
5.7 Supply Chain Analysis
5.8 Competition Product Analysis
5.9 Recent Developments

6: Orphan Drugs CDMO Market Size

6.1 Orphan Drugs CDMO Market Size, by Value
6.2 Orphan Drugs CDMO Market Size, by Volume

7: Orphan Drugs CDMO Market, by Type

7.1 Market Overview
7.2 Small Molecule
- 7.2.1 Key Market Trends & Opportunity Analysis
- 7.2.2 Market Size and Forecast, by Region
7.3 Biologics
- 7.3.1 Key Market Trends & Opportunity Analysis
- 7.3.2 Market Size and Forecast, by Region
7.4 Gene Therapy
- 7.4.1 Key Market Trends & Opportunity Analysis
- 7.4.2 Market Size and Forecast, by Region
7.5 Cell Therapy
- 7.5.1 Key Market Trends & Opportunity Analysis
- 7.5.2 Market Size and Forecast, by Region
7.6 Antibody
- 7.6.1 Key Market Trends & Opportunity Analysis
- 7.6.2 Market Size and Forecast, by Region
7.7 Peptide
- 7.7.1 Key Market Trends & Opportunity Analysis
- 7.7.2 Market Size and Forecast, by Region
7.8 RNA-based
- 7.8.1 Key Market Trends & Opportunity Analysis
- 7.8.2 Market Size and Forecast, by Region
7.9 Viral Vectors
- 7.9.1 Key Market Trends & Opportunity Analysis
- 7.9.2 Market Size and Forecast, by Region
7.10 Non-Viral Vectors
- 7.10.1 Key Market Trends & Opportunity Analysis
- 7.10.2 Market Size and Forecast, by Region
7.11 Others
- 7.11.1 Key Market Trends & Opportunity Analysis
- 7.11.2 Market Size and Forecast, by Region

8: Orphan Drugs CDMO Market, by Product

8.1 Market Overview
8.2 Active Pharmaceutical Ingredients (API)
- 8.2.1 Key Market Trends & Opportunity Analysis
- 8.2.2 Market Size and Forecast, by Region
8.3 Finished Dosage Forms (FDF)
- 8.3.1 Key Market Trends & Opportunity Analysis
- 8.3.2 Market Size and Forecast, by Region
8.4 Intermediates
- 8.4.1 Key Market Trends & Opportunity Analysis
- 8.4.2 Market Size and Forecast, by Region
8.5 Others
- 8.5.1 Key Market Trends & Opportunity Analysis
- 8.5.2 Market Size and Forecast, by Region

9: Orphan Drugs CDMO Market, by Services

9.1 Market Overview
9.2 Manufacturing
- 9.2.1 Key Market Trends & Opportunity Analysis
- 9.2.2 Market Size and Forecast, by Region
9.3 Formulation Development
- 9.3.1 Key Market Trends & Opportunity Analysis
- 9.3.2 Market Size and Forecast, by Region
9.4 Analytical and Quality Control
- 9.4.1 Key Market Trends & Opportunity Analysis
- 9.4.2 Market Size and Forecast, by Region
9.5 Regulatory Support
- 9.5.1 Key Market Trends & Opportunity Analysis
- 9.5.2 Market Size and Forecast, by Region
9.6 Clinical Trials
- 9.6.1 Key Market Trends & Opportunity Analysis
- 9.6.2 Market Size and Forecast, by Region
9.7 Supply Chain Management
- 9.7.1 Key Market Trends & Opportunity Analysis
- 9.7.2 Market Size and Forecast, by Region
9.8 Packaging
- 9.8.1 Key Market Trends & Opportunity Analysis
- 9.8.2 Market Size and Forecast, by Region
9.9 Others
- 9.9.1 Key Market Trends & Opportunity Analysis
- 9.9.2 Market Size and Forecast, by Region

10: Orphan Drugs CDMO Market, by Technology

10.1 Market Overview
10.2 Bioprocessing
- 10.2.1 Key Market Trends & Opportunity Analysis
- 10.2.2 Market Size and Forecast, by Region
10.3 Lyophilization
- 10.3.1 Key Market Trends & Opportunity Analysis
- 10.3.2 Market Size and Forecast, by Region
10.4 Spray Drying
- 10.4.1 Key Market Trends & Opportunity Analysis
- 10.4.2 Market Size and Forecast, by Region
10.5 Microencapsulation
- 10.5.1 Key Market Trends & Opportunity Analysis
- 10.5.2 Market Size and Forecast, by Region
10.6 Nanoparticle Engineering
- 10.6.1 Key Market Trends & Opportunity Analysis
- 10.6.2 Market Size and Forecast, by Region
10.7 Continuous Manufacturing
- 10.7.1 Key Market Trends & Opportunity Analysis
- 10.7.2 Market Size and Forecast, by Region
10.8 Others
- 10.8.1 Key Market Trends & Opportunity Analysis
- 10.8.2 Market Size and Forecast, by Region

11: Orphan Drugs CDMO Market, by Application

11.1 Market Overview
11.2 Oncology
- 11.2.1 Key Market Trends & Opportunity Analysis
- 11.2.2 Market Size and Forecast, by Region
11.3 Neurology
- 11.3.1 Key Market Trends & Opportunity Analysis
- 11.3.2 Market Size and Forecast, by Region
11.4 Hematology
- 11.4.1 Key Market Trends & Opportunity Analysis
- 11.4.2 Market Size and Forecast, by Region
11.5 Cardiology
- 11.5.1 Key Market Trends & Opportunity Analysis
- 11.5.2 Market Size and Forecast, by Region
11.6 Metabolic Disorders
- 11.6.1 Key Market Trends & Opportunity Analysis
- 11.6.2 Market Size and Forecast, by Region
11.7 Infectious Diseases
- 11.7.1 Key Market Trends & Opportunity Analysis
- 11.7.2 Market Size and Forecast, by Region
11.8 Genetic Disorders
- 11.8.1 Key Market Trends & Opportunity Analysis
- 11.8.2 Market Size and Forecast, by Region
11.9 Others
- 11.9.1 Key Market Trends & Opportunity Analysis
- 11.9.2 Market Size and Forecast, by Region

12: Orphan Drugs CDMO Market, by End User

12.1 Market Overview
12.2 Pharmaceutical Companies
- 12.2.1 Key Market Trends & Opportunity Analysis
- 12.2.2 Market Size and Forecast, by Region
12.3 Biotechnology Firms
- 12.3.1 Key Market Trends & Opportunity Analysis
- 12.3.2 Market Size and Forecast, by Region
12.4 Research and Academic Institutes
- 12.4.1 Key Market Trends & Opportunity Analysis
- 12.4.2 Market Size and Forecast, by Region
12.5 Contract Research Organizations (CROs)
- 12.5.1 Key Market Trends & Opportunity Analysis
- 12.5.2 Market Size and Forecast, by Region
12.6 Others
- 12.6.1 Key Market Trends & Opportunity Analysis
- 12.6.2 Market Size and Forecast, by Region

13: Orphan Drugs CDMO Market, by Stage

13.1 Market Overview
13.2 Preclinical
- 13.2.1 Key Market Trends & Opportunity Analysis
- 13.2.2 Market Size and Forecast, by Region
13.3 Phase I
- 13.3.1 Key Market Trends & Opportunity Analysis
- 13.3.2 Market Size and Forecast, by Region
13.4 Phase II
- 13.4.1 Key Market Trends & Opportunity Analysis
- 13.4.2 Market Size and Forecast, by Region
13.5 Phase III
- 13.5.1 Key Market Trends & Opportunity Analysis
- 13.5.2 Market Size and Forecast, by Region
13.6 Commercial
- 13.6.1 Key Market Trends & Opportunity Analysis
- 13.6.2 Market Size and Forecast, by Region
13.7 Others
- 13.7.1 Key Market Trends & Opportunity Analysis
- 13.7.2 Market Size and Forecast, by Region

14: Orphan Drugs CDMO Market, by Process

14.1 Market Overview
14.2 Upstream
- 14.2.1 Key Market Trends & Opportunity Analysis
- 14.2.2 Market Size and Forecast, by Region
14.3 Downstream
- 14.3.1 Key Market Trends & Opportunity Analysis
- 14.3.2 Market Size and Forecast, by Region
14.4 Formulation
- 14.4.1 Key Market Trends & Opportunity Analysis
- 14.4.2 Market Size and Forecast, by Region
14.5 Others
- 14.5.1 Key Market Trends & Opportunity Analysis
- 14.5.2 Market Size and Forecast, by Region

15: Orphan Drugs CDMO Market, by Mode

15.1 Market Overview
15.2 In-house
- 15.2.1 Key Market Trends & Opportunity Analysis
- 15.2.2 Market Size and Forecast, by Region
15.3 Outsourced
- 15.3.1 Key Market Trends & Opportunity Analysis
- 15.3.2 Market Size and Forecast, by Region
15.4 Others
- 15.4.1 Key Market Trends & Opportunity Analysis
- 15.4.2 Market Size and Forecast, by Region

16: Orphan Drugs CDMO Market, by Component

16.1 Market Overview
16.2 Equipment
- 16.2.1 Key Market Trends & Opportunity Analysis
- 16.2.2 Market Size and Forecast, by Region
16.3 Consumables
- 16.3.1 Key Market Trends & Opportunity Analysis
- 16.3.2 Market Size and Forecast, by Region
16.4 Software
- 16.4.1 Key Market Trends & Opportunity Analysis
- 16.4.2 Market Size and Forecast, by Region
16.5 Others
- 16.5.1 Key Market Trends & Opportunity Analysis
- 16.5.2 Market Size and Forecast, by Region

17: Orphan Drugs CDMO Market, by Region

17.1 Overview
17.2 North America
- 17.2.1 Key Market Trends and Opportunities
- 17.2.2 North America Market Size and Forecast, by Type
- 17.2.3 North America Market Size and Forecast, by Product
- 17.2.4 North America Market Size and Forecast, by Services
- 17.2.5 North America Market Size and Forecast, by Technology
- 17.2.6 North America Market Size and Forecast, by Application
- 17.2.7 North America Market Size and Forecast, by End User
- 17.2.8 North America Market Size and Forecast, by Stage
- 17.2.9 North America Market Size and Forecast, by Process
- 17.2.10 North America Market Size and Forecast, by Mode
- 17.2.11 North America Market Size and Forecast, by Component
- 17.2.12 North America Market Size and Forecast, by Country
- 17.2.13 United States
  - 17.2.9.1 United States Market Size and Forecast, by Type
  - 17.2.9.2 United States Market Size and Forecast, by Product
  - 17.2.9.3 United States Market Size and Forecast, by Services
  - 17.2.9.4 United States Market Size and Forecast, by Technology
  - 17.2.9.5 United States Market Size and Forecast, by Application
  - 17.2.9.6 United States Market Size and Forecast, by End User
  - 17.2.9.7 United States Market Size and Forecast, by Stage
  - 17.2.9.8 United States Market Size and Forecast, by Process
  - 17.2.9.9 United States Market Size and Forecast, by Mode
  - 17.2.9.10 United States Market Size and Forecast, by Component
  - 17.2.9.11 Local Competition Analysis
  - 17.2.9.12 Local Market Analysis
- 17.2.1 Canada
  - 17.2.10.1 Canada Market Size and Forecast, by Type
  - 17.2.10.2 Canada Market Size and Forecast, by Product
  - 17.2.10.3 Canada Market Size and Forecast, by Services
  - 17.2.10.4 Canada Market Size and Forecast, by Technology
  - 17.2.10.5 Canada Market Size and Forecast, by Application
  - 17.2.10.6 Canada Market Size and Forecast, by End User
  - 17.2.10.7 Canada Market Size and Forecast, by Stage
  - 17.2.10.8 Canada Market Size and Forecast, by Process
  - 17.2.10.9 Canada Market Size and Forecast, by Mode
  - 17.2.10.10 Canada Market Size and Forecast, by Component
  - 17.2.10.11 Local Competition Analysis
  - 17.2.10.12 Local Market Analysis
17.1 Europe
- 17.3.1 Key Market Trends and Opportunities
- 17.3.2 Europe Market Size and Forecast, by Type
- 17.3.3 Europe Market Size and Forecast, by Product
- 17.3.4 Europe Market Size and Forecast, by Services
- 17.3.5 Europe Market Size and Forecast, by Technology
- 17.3.6 Europe Market Size and Forecast, by Application
- 17.3.7 Europe Market Size and Forecast, by End User
- 17.3.8 Europe Market Size and Forecast, by Stage
- 17.3.9 Europe Market Size and Forecast, by Process
- 17.3.10 Europe Market Size and Forecast, by Mode
- 17.3.11 Europe Market Size and Forecast, by Component
- 17.3.12 Europe Market Size and Forecast, by Country
- 17.3.13 United Kingdom
  - 17.3.9.1 United Kingdom Market Size and Forecast, by Type
  - 17.3.9.2 United Kingdom Market Size and Forecast, by Product
  - 17.3.9.3 United Kingdom Market Size and Forecast, by Services
  - 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
  - 17.3.9.5 United Kingdom Market Size and Forecast, by Application
  - 17.3.9.6 United Kingdom Market Size and Forecast, by End User
  - 17.3.9.7 United Kingdom Market Size and Forecast, by Stage
  - 17.3.9.8 United Kingdom Market Size and Forecast, by Process
  - 17.3.9.9 United Kingdom Market Size and Forecast, by Mode
  - 17.3.9.10 United Kingdom Market Size and Forecast, by Component
  - 17.3.9.11 Local Competition Analysis
  - 17.3.9.12 Local Market Analysis
- 17.3.1 Germany
  - 17.3.10.1 Germany Market Size and Forecast, by Type
  - 17.3.10.2 Germany Market Size and Forecast, by Product
  - 17.3.10.3 Germany Market Size and Forecast, by Services
  - 17.3.10.4 Germany Market Size and Forecast, by Technology
  - 17.3.10.5 Germany Market Size and Forecast, by Application
  - 17.3.10.6 Germany Market Size and Forecast, by End User
  - 17.3.10.7 Germany Market Size and Forecast, by Stage
  - 17.3.10.8 Germany Market Size and Forecast, by Process
  - 17.3.10.9 Germany Market Size and Forecast, by Mode
  - 17.3.10.10 Germany Market Size and Forecast, by Component
  - 17.3.10.11 Local Competition Analysis
  - 17.3.10.12 Local Market Analysis
- 17.3.1 France
  - 17.3.11.1 France Market Size and Forecast, by Type
  - 17.3.11.2 France Market Size and Forecast, by Product
  - 17.3.11.3 France Market Size and Forecast, by Services
  - 17.3.11.4 France Market Size and Forecast, by Technology
  - 17.3.11.5 France Market Size and Forecast, by Application
  - 17.3.11.6 France Market Size and Forecast, by End User
  - 17.3.11.7 France Market Size and Forecast, by Stage
  - 17.3.11.8 France Market Size and Forecast, by Process
  - 17.3.11.9 France Market Size and Forecast, by Mode
  - 17.3.11.10 France Market Size and Forecast, by Component
  - 17.3.11.11 Local Competition Analysis
  - 17.3.11.12 Local Market Analysis
- 17.3.1 Spain
  - 17.3.12.1 Spain Market Size and Forecast, by Type
  - 17.3.12.2 Spain Market Size and Forecast, by Product
  - 17.3.12.3 Spain Market Size and Forecast, by Services
  - 17.3.12.4 Spain Market Size and Forecast, by Technology
  - 17.3.12.5 Spain Market Size and Forecast, by Application
  - 17.3.12.6 Spain Market Size and Forecast, by End User
  - 17.3.12.7 Spain Market Size and Forecast, by Stage
  - 17.3.12.8 Spain Market Size and Forecast, by Process
  - 17.3.12.9 Spain Market Size and Forecast, by Mode
  - 17.3.12.10 Spain Market Size and Forecast, by Component
  - 17.3.12.11 Local Competition Analysis
  - 17.3.12.12 Local Market Analysis
- 17.3.1 Italy
  - 17.3.13.1 Italy Market Size and Forecast, by Type
  - 17.3.13.2 Italy Market Size and Forecast, by Product
  - 17.3.13.3 Italy Market Size and Forecast, by Services
  - 17.3.13.4 Italy Market Size and Forecast, by Technology
  - 17.3.13.5 Italy Market Size and Forecast, by Application
  - 17.3.13.6 Italy Market Size and Forecast, by End User
  - 17.3.13.7 Italy Market Size and Forecast, by Stage
  - 17.3.13.8 Italy Market Size and Forecast, by Process
  - 17.3.13.9 Italy Market Size and Forecast, by Mode
  - 17.3.13.10 Italy Market Size and Forecast, by Component
  - 17.3.13.11 Local Competition Analysis
  - 17.3.13.12 Local Market Analysis
- 17.3.1 Netherlands
  - 17.3.14.1 Netherlands Market Size and Forecast, by Type
  - 17.3.14.2 Netherlands Market Size and Forecast, by Product
  - 17.3.14.3 Netherlands Market Size and Forecast, by Services
  - 17.3.14.4 Netherlands Market Size and Forecast, by Technology
  - 17.3.14.5 Netherlands Market Size and Forecast, by Application
  - 17.3.14.6 Netherlands Market Size and Forecast, by End User
  - 17.3.14.7 Netherlands Market Size and Forecast, by Stage
  - 17.3.14.8 Netherlands Market Size and Forecast, by Process
  - 17.3.14.9 Netherlands Market Size and Forecast, by Mode
  - 17.3.14.10 Netherlands Market Size and Forecast, by Component
  - 17.3.14.11 Local Competition Analysis
  - 17.3.14.12 Local Market Analysis
- 17.3.1 Sweden
  - 17.3.15.1 Sweden Market Size and Forecast, by Type
  - 17.3.15.2 Sweden Market Size and Forecast, by Product
  - 17.3.15.3 Sweden Market Size and Forecast, by Services
  - 17.3.15.4 Sweden Market Size and Forecast, by Technology
  - 17.3.15.5 Sweden Market Size and Forecast, by Application
  - 17.3.15.6 Sweden Market Size and Forecast, by End User
  - 17.3.15.7 Sweden Market Size and Forecast, by Stage
  - 17.3.15.8 Sweden Market Size and Forecast, by Process
  - 17.3.15.9 Sweden Market Size and Forecast, by Mode
  - 17.3.15.10 Sweden Market Size and Forecast, by Component
  - 17.3.15.11 Local Competition Analysis
  - 17.3.15.12 Local Market Analysis
- 17.3.1 Switzerland
  - 17.3.16.1 Switzerland Market Size and Forecast, by Type
  - 17.3.16.2 Switzerland Market Size and Forecast, by Product
  - 17.3.16.3 Switzerland Market Size and Forecast, by Services
  - 17.3.16.4 Switzerland Market Size and Forecast, by Technology
  - 17.3.16.5 Switzerland Market Size and Forecast, by Application
  - 17.3.16.6 Switzerland Market Size and Forecast, by End User
  - 17.3.16.7 Switzerland Market Size and Forecast, by Stage
  - 17.3.16.8 Switzerland Market Size and Forecast, by Process
  - 17.3.16.9 Switzerland Market Size and Forecast, by Mode
  - 17.3.16.10 Switzerland Market Size and Forecast, by Component
  - 17.3.16.11 Local Competition Analysis
  - 17.3.16.12 Local Market Analysis
- 17.3.1 Denmark
  - 17.3.17.1 Denmark Market Size and Forecast, by Type
  - 17.3.17.2 Denmark Market Size and Forecast, by Product
  - 17.3.17.3 Denmark Market Size and Forecast, by Services
  - 17.3.17.4 Denmark Market Size and Forecast, by Technology
  - 17.3.17.5 Denmark Market Size and Forecast, by Application
  - 17.3.17.6 Denmark Market Size and Forecast, by End User
  - 17.3.17.7 Denmark Market Size and Forecast, by Stage
  - 17.3.17.8 Denmark Market Size and Forecast, by Process
  - 17.3.17.9 Denmark Market Size and Forecast, by Mode
  - 17.3.17.10 Denmark Market Size and Forecast, by Component
  - 17.3.17.11 Local Competition Analysis
  - 17.3.17.12 Local Market Analysis
- 17.3.1 Finland
  - 17.3.18.1 Finland Market Size and Forecast, by Type
  - 17.3.18.2 Finland Market Size and Forecast, by Product
  - 17.3.18.3 Finland Market Size and Forecast, by Services
  - 17.3.18.4 Finland Market Size and Forecast, by Technology
  - 17.3.18.5 Finland Market Size and Forecast, by Application
  - 17.3.18.6 Finland Market Size and Forecast, by End User
  - 17.3.18.7 Finland Market Size and Forecast, by Stage
  - 17.3.18.8 Finland Market Size and Forecast, by Process
  - 17.3.18.9 Finland Market Size and Forecast, by Mode
  - 17.3.18.10 Finland Market Size and Forecast, by Component
  - 17.3.18.11 Local Competition Analysis
  - 17.3.18.12 Local Market Analysis
- 17.3.1 Russia
  - 17.3.19.1 Russia Market Size and Forecast, by Type
  - 17.3.19.2 Russia Market Size and Forecast, by Product
  - 17.3.19.3 Russia Market Size and Forecast, by Services
  - 17.3.19.4 Russia Market Size and Forecast, by Technology
  - 17.3.19.5 Russia Market Size and Forecast, by Application
  - 17.3.19.6 Russia Market Size and Forecast, by End User
  - 17.3.19.7 Russia Market Size and Forecast, by Stage
  - 17.3.19.8 Russia Market Size and Forecast, by Process
  - 17.3.19.9 Russia Market Size and Forecast, by Mode
  - 17.3.19.10 Russia Market Size and Forecast, by Component
  - 17.3.19.11 Local Competition Analysis
  - 17.3.19.12 Local Market Analysis
- 17.3.1 Rest of Europe
  - 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
  - 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
  - 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
  - 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
  - 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
  - 17.3.20.6 Rest of Europe Market Size and Forecast, by End User
  - 17.3.20.7 Rest of Europe Market Size and Forecast, by Stage
  - 17.3.20.8 Rest of Europe Market Size and Forecast, by Process
  - 17.3.20.9 Rest of Europe Market Size and Forecast, by Mode
  - 17.3.20.10 Rest of Europe Market Size and Forecast, by Component
  - 17.3.20.11 Local Competition Analysis
  - 17.3.20.12 Local Market Analysis
17.1 Asia-Pacific
- 17.4.1 Key Market Trends and Opportunities
- 17.4.2 Asia-Pacific Market Size and Forecast, by Type
- 17.4.3 Asia-Pacific Market Size and Forecast, by Product
- 17.4.4 Asia-Pacific Market Size and Forecast, by Services
- 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
- 17.4.6 Asia-Pacific Market Size and Forecast, by Application
- 17.4.7 Asia-Pacific Market Size and Forecast, by End User
- 17.4.8 Asia-Pacific Market Size and Forecast, by Stage
- 17.4.9 Asia-Pacific Market Size and Forecast, by Process
- 17.4.10 Asia-Pacific Market Size and Forecast, by Mode
- 17.4.11 Asia-Pacific Market Size and Forecast, by Component
- 17.4.12 Asia-Pacific Market Size and Forecast, by Country
- 17.4.13 China
  - 17.4.9.1 China Market Size and Forecast, by Type
  - 17.4.9.2 China Market Size and Forecast, by Product
  - 17.4.9.3 China Market Size and Forecast, by Services
  - 17.4.9.4 China Market Size and Forecast, by Technology
  - 17.4.9.5 China Market Size and Forecast, by Application
  - 17.4.9.6 China Market Size and Forecast, by End User
  - 17.4.9.7 China Market Size and Forecast, by Stage
  - 17.4.9.8 China Market Size and Forecast, by Process
  - 17.4.9.9 China Market Size and Forecast, by Mode
  - 17.4.9.10 China Market Size and Forecast, by Component
  - 17.4.9.11 Local Competition Analysis
  - 17.4.9.12 Local Market Analysis
- 17.4.1 India
  - 17.4.10.1 India Market Size and Forecast, by Type
  - 17.4.10.2 India Market Size and Forecast, by Product
  - 17.4.10.3 India Market Size and Forecast, by Services
  - 17.4.10.4 India Market Size and Forecast, by Technology
  - 17.4.10.5 India Market Size and Forecast, by Application
  - 17.4.10.6 India Market Size and Forecast, by End User
  - 17.4.10.7 India Market Size and Forecast, by Stage
  - 17.4.10.8 India Market Size and Forecast, by Process
  - 17.4.10.9 India Market Size and Forecast, by Mode
  - 17.4.10.10 India Market Size and Forecast, by Component
  - 17.4.10.11 Local Competition Analysis
  - 17.4.10.12 Local Market Analysis
- 17.4.1 Japan
  - 17.4.11.1 Japan Market Size and Forecast, by Type
  - 17.4.11.2 Japan Market Size and Forecast, by Product
  - 17.4.11.3 Japan Market Size and Forecast, by Services
  - 17.4.11.4 Japan Market Size and Forecast, by Technology
  - 17.4.11.5 Japan Market Size and Forecast, by Application
  - 17.4.11.6 Japan Market Size and Forecast, by End User
  - 17.4.11.7 Japan Market Size and Forecast, by Stage
  - 17.4.11.8 Japan Market Size and Forecast, by Process
  - 17.4.11.9 Japan Market Size and Forecast, by Mode
  - 17.4.11.10 Japan Market Size and Forecast, by Component
  - 17.4.11.11 Local Competition Analysis
  - 17.4.11.12 Local Market Analysis
- 17.4.1 South Korea
  - 17.4.12.1 South Korea Market Size and Forecast, by Type
  - 17.4.12.2 South Korea Market Size and Forecast, by Product
  - 17.4.12.3 South Korea Market Size and Forecast, by Services
  - 17.4.12.4 South Korea Market Size and Forecast, by Technology
  - 17.4.12.5 South Korea Market Size and Forecast, by Application
  - 17.4.12.6 South Korea Market Size and Forecast, by End User
  - 17.4.12.7 South Korea Market Size and Forecast, by Stage
  - 17.4.12.8 South Korea Market Size and Forecast, by Process
  - 17.4.12.9 South Korea Market Size and Forecast, by Mode
  - 17.4.12.10 South Korea Market Size and Forecast, by Component
  - 17.4.12.11 Local Competition Analysis
  - 17.4.12.12 Local Market Analysis
- 17.4.1 Australia
  - 17.4.13.1 Australia Market Size and Forecast, by Type
  - 17.4.13.2 Australia Market Size and Forecast, by Product
  - 17.4.13.3 Australia Market Size and Forecast, by Services
  - 17.4.13.4 Australia Market Size and Forecast, by Technology
  - 17.4.13.5 Australia Market Size and Forecast, by Application
  - 17.4.13.6 Australia Market Size and Forecast, by End User
  - 17.4.13.7 Australia Market Size and Forecast, by Stage
  - 17.4.13.8 Australia Market Size and Forecast, by Process
  - 17.4.13.9 Australia Market Size and Forecast, by Mode
  - 17.4.13.10 Australia Market Size and Forecast, by Component
  - 17.4.13.11 Local Competition Analysis
  - 17.4.13.12 Local Market Analysis
- 17.4.1 Singapore
  - 17.4.14.1 Singapore Market Size and Forecast, by Type
  - 17.4.14.2 Singapore Market Size and Forecast, by Product
  - 17.4.14.3 Singapore Market Size and Forecast, by Services
  - 17.4.14.4 Singapore Market Size and Forecast, by Technology
  - 17.4.14.5 Singapore Market Size and Forecast, by Application
  - 17.4.14.6 Singapore Market Size and Forecast, by End User
  - 17.4.14.7 Singapore Market Size and Forecast, by Stage
  - 17.4.14.8 Singapore Market Size and Forecast, by Process
  - 17.4.14.9 Singapore Market Size and Forecast, by Mode
  - 17.4.14.10 Singapore Market Size and Forecast, by Component
  - 17.4.14.11 Local Competition Analysis
  - 17.4.14.12 Local Market Analysis
- 17.4.1 Indonesia
  - 17.4.15.1 Indonesia Market Size and Forecast, by Type
  - 17.4.15.2 Indonesia Market Size and Forecast, by Product
  - 17.4.15.3 Indonesia Market Size and Forecast, by Services
  - 17.4.15.4 Indonesia Market Size and Forecast, by Technology
  - 17.4.15.5 Indonesia Market Size and Forecast, by Application
  - 17.4.15.6 Indonesia Market Size and Forecast, by End User
  - 17.4.15.7 Indonesia Market Size and Forecast, by Stage
  - 17.4.15.8 Indonesia Market Size and Forecast, by Process
  - 17.4.15.9 Indonesia Market Size and Forecast, by Mode
  - 17.4.15.10 Indonesia Market Size and Forecast, by Component
  - 17.4.15.11 Local Competition Analysis
  - 17.4.15.12 Local Market Analysis
- 17.4.1 Taiwan
  - 17.4.16.1 Taiwan Market Size and Forecast, by Type
  - 17.4.16.2 Taiwan Market Size and Forecast, by Product
  - 17.4.16.3 Taiwan Market Size and Forecast, by Services
  - 17.4.16.4 Taiwan Market Size and Forecast, by Technology
  - 17.4.16.5 Taiwan Market Size and Forecast, by Application
  - 17.4.16.6 Taiwan Market Size and Forecast, by End User
  - 17.4.16.7 Taiwan Market Size and Forecast, by Stage
  - 17.4.16.8 Taiwan Market Size and Forecast, by Process
  - 17.4.16.9 Taiwan Market Size and Forecast, by Mode
  - 17.4.16.10 Taiwan Market Size and Forecast, by Component
  - 17.4.16.11 Local Competition Analysis
  - 17.4.16.12 Local Market Analysis
- 17.4.1 Malaysia
  - 17.4.17.1 Malaysia Market Size and Forecast, by Type
  - 17.4.17.2 Malaysia Market Size and Forecast, by Product
  - 17.4.17.3 Malaysia Market Size and Forecast, by Services
  - 17.4.17.4 Malaysia Market Size and Forecast, by Technology
  - 17.4.17.5 Malaysia Market Size and Forecast, by Application
  - 17.4.17.6 Malaysia Market Size and Forecast, by End User
  - 17.4.17.7 Malaysia Market Size and Forecast, by Stage
  - 17.4.17.8 Malaysia Market Size and Forecast, by Process
  - 17.4.17.9 Malaysia Market Size and Forecast, by Mode
  - 17.4.17.10 Malaysia Market Size and Forecast, by Component
  - 17.4.17.11 Local Competition Analysis
  - 17.4.17.12 Local Market Analysis
- 17.4.1 Rest of Asia-Pacific
  - 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
  - 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
  - 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
  - 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
  - 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
  - 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
  - 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Stage
  - 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Process
  - 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Mode
  - 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Component
  - 17.4.18.11 Local Competition Analysis
  - 17.4.18.12 Local Market Analysis
17.1 Latin America
- 17.5.1 Key Market Trends and Opportunities
- 17.5.2 Latin America Market Size and Forecast, by Type
- 17.5.3 Latin America Market Size and Forecast, by Product
- 17.5.4 Latin America Market Size and Forecast, by Services
- 17.5.5 Latin America Market Size and Forecast, by Technology
- 17.5.6 Latin America Market Size and Forecast, by Application
- 17.5.7 Latin America Market Size and Forecast, by End User
- 17.5.8 Latin America Market Size and Forecast, by Stage
- 17.5.9 Latin America Market Size and Forecast, by Process
- 17.5.10 Latin America Market Size and Forecast, by Mode
- 17.5.11 Latin America Market Size and Forecast, by Component
- 17.5.12 Latin America Market Size and Forecast, by Country
- 17.5.13 Brazil
  - 17.5.9.1 Brazil Market Size and Forecast, by Type
  - 17.5.9.2 Brazil Market Size and Forecast, by Product
  - 17.5.9.3 Brazil Market Size and Forecast, by Services
  - 17.5.9.4 Brazil Market Size and Forecast, by Technology
  - 17.5.9.5 Brazil Market Size and Forecast, by Application
  - 17.5.9.6 Brazil Market Size and Forecast, by End User
  - 17.5.9.7 Brazil Market Size and Forecast, by Stage
  - 17.5.9.8 Brazil Market Size and Forecast, by Process
  - 17.5.9.9 Brazil Market Size and Forecast, by Mode
  - 17.5.9.10 Brazil Market Size and Forecast, by Component
  - 17.5.9.11 Local Competition Analysis
  - 17.5.9.12 Local Market Analysis
- 17.5.1 Mexico
  - 17.5.10.1 Mexico Market Size and Forecast, by Type
  - 17.5.10.2 Mexico Market Size and Forecast, by Product
  - 17.5.10.3 Mexico Market Size and Forecast, by Services
  - 17.5.10.4 Mexico Market Size and Forecast, by Technology
  - 17.5.10.5 Mexico Market Size and Forecast, by Application
  - 17.5.10.6 Mexico Market Size and Forecast, by End User
  - 17.5.10.7 Mexico Market Size and Forecast, by Stage
  - 17.5.10.8 Mexico Market Size and Forecast, by Process
  - 17.5.10.9 Mexico Market Size and Forecast, by Mode
  - 17.5.10.10 Mexico Market Size and Forecast, by Component
  - 17.5.10.11 Local Competition Analysis
  - 17.5.10.12 Local Market Analysis
- 17.5.1 Argentina
  - 17.5.11.1 Argentina Market Size and Forecast, by Type
  - 17.5.11.2 Argentina Market Size and Forecast, by Product
  - 17.5.11.3 Argentina Market Size and Forecast, by Services
  - 17.5.11.4 Argentina Market Size and Forecast, by Technology
  - 17.5.11.5 Argentina Market Size and Forecast, by Application
  - 17.5.11.6 Argentina Market Size and Forecast, by End User
  - 17.5.11.7 Argentina Market Size and Forecast, by Stage
  - 17.5.11.8 Argentina Market Size and Forecast, by Process
  - 17.5.11.9 Argentina Market Size and Forecast, by Mode
  - 17.5.11.10 Argentina Market Size and Forecast, by Component
  - 17.5.11.11 Local Competition Analysis
  - 17.5.11.12 Local Market Analysis
- 17.5.1 Rest of Latin America
  - 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
  - 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
  - 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
  - 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
  - 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
  - 17.5.12.6 Rest of Latin America Market Size and Forecast, by End User
  - 17.5.12.7 Rest of Latin America Market Size and Forecast, by Stage
  - 17.5.12.8 Rest of Latin America Market Size and Forecast, by Process
  - 17.5.12.9 Rest of Latin America Market Size and Forecast, by Mode
  - 17.5.12.10 Rest of Latin America Market Size and Forecast, by Component
  - 17.5.12.11 Local Competition Analysis
  - 17.5.12.12 Local Market Analysis
17.1 Middle East and Africa
- 17.6.1 Key Market Trends and Opportunities
- 17.6.2 Middle East and Africa Market Size and Forecast, by Type
- 17.6.3 Middle East and Africa Market Size and Forecast, by Product
- 17.6.4 Middle East and Africa Market Size and Forecast, by Services
- 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
- 17.6.6 Middle East and Africa Market Size and Forecast, by Application
- 17.6.7 Middle East and Africa Market Size and Forecast, by End User
- 17.6.8 Middle East and Africa Market Size and Forecast, by Stage
- 17.6.9 Middle East and Africa Market Size and Forecast, by Process
- 17.6.10 Middle East and Africa Market Size and Forecast, by Mode
- 17.6.11 Middle East and Africa Market Size and Forecast, by Component
- 17.6.12 Middle East and Africa Market Size and Forecast, by Country
- 17.6.13 Saudi Arabia
  - 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
  - 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
  - 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
  - 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
  - 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
  - 17.6.9.6 Saudi Arabia Market Size and Forecast, by End User
  - 17.6.9.7 Saudi Arabia Market Size and Forecast, by Stage
  - 17.6.9.8 Saudi Arabia Market Size and Forecast, by Process
  - 17.6.9.9 Saudi Arabia Market Size and Forecast, by Mode
  - 17.6.9.10 Saudi Arabia Market Size and Forecast, by Component
  - 17.6.9.11 Local Competition Analysis
  - 17.6.9.12 Local Market Analysis
- 17.6.1 UAE
  - 17.6.10.1 UAE Market Size and Forecast, by Type
  - 17.6.10.2 UAE Market Size and Forecast, by Product
  - 17.6.10.3 UAE Market Size and Forecast, by Services
  - 17.6.10.4 UAE Market Size and Forecast, by Technology
  - 17.6.10.5 UAE Market Size and Forecast, by Application
  - 17.6.10.6 UAE Market Size and Forecast, by End User
  - 17.6.10.7 UAE Market Size and Forecast, by Stage
  - 17.6.10.8 UAE Market Size and Forecast, by Process
  - 17.6.10.9 UAE Market Size and Forecast, by Mode
  - 17.6.10.10 UAE Market Size and Forecast, by Component
  - 17.6.10.11 Local Competition Analysis
  - 17.6.10.12 Local Market Analysis
- 17.6.1 South Africa
  - 17.6.11.1 South Africa Market Size and Forecast, by Type
  - 17.6.11.2 South Africa Market Size and Forecast, by Product
  - 17.6.11.3 South Africa Market Size and Forecast, by Services
  - 17.6.11.4 South Africa Market Size and Forecast, by Technology
  - 17.6.11.5 South Africa Market Size and Forecast, by Application
  - 17.6.11.6 South Africa Market Size and Forecast, by End User
  - 17.6.11.7 South Africa Market Size and Forecast, by Stage
  - 17.6.11.8 South Africa Market Size and Forecast, by Process
  - 17.6.11.9 South Africa Market Size and Forecast, by Mode
  - 17.6.11.10 South Africa Market Size and Forecast, by Component
  - 17.6.11.11 Local Competition Analysis
  - 17.6.11.12 Local Market Analysis
- 17.6.1 Rest of MEA
  - 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
  - 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
  - 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
  - 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
  - 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
  - 17.6.12.6 Rest of MEA Market Size and Forecast, by End User
  - 17.6.12.7 Rest of MEA Market Size and Forecast, by Stage
  - 17.6.12.8 Rest of MEA Market Size and Forecast, by Process
  - 17.6.12.9 Rest of MEA Market Size and Forecast, by Mode
  - 17.6.12.10 Rest of MEA Market Size and Forecast, by Component
  - 17.6.12.11 Local Competition Analysis
  - 17.6.12.12 Local Market Analysis

18: Competitive Landscape

18.1 Overview
18.2 Market Share Analysis
18.3 Key Player Positioning
18.4 Competitive Leadership Mapping
- 18.4.1 Star Players
- 18.4.2 Innovators
- 18.4.3 Emerging Players
18.5 Vendor Benchmarking
18.6 Developmental Strategy Benchmarking
- 18.6.1 New Product Developments
- 18.6.2 Product Launches
- 18.6.3 Business Expansions
- 18.6.4 Partnerships, Joint Ventures, and Collaborations
- 18.6.5 Mergers and Acquisitions

19: Company Profiles

19.1 Lonza
- 19.1.1 Company Overview
- 19.1.2 Company Snapshot
- 19.1.3 Business Segments
- 19.1.4 Business Performance
- 19.1.5 Product Offerings
- 19.1.6 Key Developmental Strategies
- 19.1.7 SWOT Analysis
19.2 Catalent
- 19.2.1 Company Overview
- 19.2.2 Company Snapshot
- 19.2.3 Business Segments
- 19.2.4 Business Performance
- 19.2.5 Product Offerings
- 19.2.6 Key Developmental Strategies
- 19.2.7 SWOT Analysis
19.3 Samsung Biologics
- 19.3.1 Company Overview
- 19.3.2 Company Snapshot
- 19.3.3 Business Segments
- 19.3.4 Business Performance
- 19.3.5 Product Offerings
- 19.3.6 Key Developmental Strategies
- 19.3.7 SWOT Analysis
19.4 WuXi Biologics
- 19.4.1 Company Overview
- 19.4.2 Company Snapshot
- 19.4.3 Business Segments
- 19.4.4 Business Performance
- 19.4.5 Product Offerings
- 19.4.6 Key Developmental Strategies
- 19.4.7 SWOT Analysis
19.5 Boehringer Ingelheim BioXcellence
- 19.5.1 Company Overview
- 19.5.2 Company Snapshot
- 19.5.3 Business Segments
- 19.5.4 Business Performance
- 19.5.5 Product Offerings
- 19.5.6 Key Developmental Strategies
- 19.5.7 SWOT Analysis
19.6 Fujifilm Diosynth Biotechnologies
- 19.6.1 Company Overview
- 19.6.2 Company Snapshot
- 19.6.3 Business Segments
- 19.6.4 Business Performance
- 19.6.5 Product Offerings
- 19.6.6 Key Developmental Strategies
- 19.6.7 SWOT Analysis
19.7 AGC Biologics
- 19.7.1 Company Overview
- 19.7.2 Company Snapshot
- 19.7.3 Business Segments
- 19.7.4 Business Performance
- 19.7.5 Product Offerings
- 19.7.6 Key Developmental Strategies
- 19.7.7 SWOT Analysis
19.8 Thermo Fisher Scientific
- 19.8.1 Company Overview
- 19.8.2 Company Snapshot
- 19.8.3 Business Segments
- 19.8.4 Business Performance
- 19.8.5 Product Offerings
- 19.8.6 Key Developmental Strategies
- 19.8.7 SWOT Analysis
19.9 Recipharm
- 19.9.1 Company Overview
- 19.9.2 Company Snapshot
- 19.9.3 Business Segments
- 19.9.4 Business Performance
- 19.9.5 Product Offerings
- 19.9.6 Key Developmental Strategies
- 19.9.7 SWOT Analysis
19.10 Piramal Pharma Solutions
- 19.10.1 Company Overview
- 19.10.2 Company Snapshot
- 19.10.3 Business Segments
- 19.10.4 Business Performance
- 19.10.5 Product Offerings
- 19.10.6 Key Developmental Strategies
- 19.10.7 SWOT Analysis
19.11 Almac Group
- 19.11.1 Company Overview
- 19.11.2 Company Snapshot
- 19.11.3 Business Segments
- 19.11.4 Business Performance
- 19.11.5 Product Offerings
- 19.11.6 Key Developmental Strategies
- 19.11.7 SWOT Analysis
19.12 Biocon
- 19.12.1 Company Overview
- 19.12.2 Company Snapshot
- 19.12.3 Business Segments
- 19.12.4 Business Performance
- 19.12.5 Product Offerings
- 19.12.6 Key Developmental Strategies
- 19.12.7 SWOT Analysis
19.13 CordenPharma
- 19.13.1 Company Overview
- 19.13.2 Company Snapshot
- 19.13.3 Business Segments
- 19.13.4 Business Performance
- 19.13.5 Product Offerings
- 19.13.6 Key Developmental Strategies
- 19.13.7 SWOT Analysis
19.14 Patheon
- 19.14.1 Company Overview
- 19.14.2 Company Snapshot
- 19.14.3 Business Segments
- 19.14.4 Business Performance
- 19.14.5 Product Offerings
- 19.14.6 Key Developmental Strategies
- 19.14.7 SWOT Analysis
19.15 Ajinomoto Bio-Pharma Services
- 19.15.1 Company Overview
- 19.15.2 Company Snapshot
- 19.15.3 Business Segments
- 19.15.4 Business Performance
- 19.15.5 Product Offerings
- 19.15.6 Key Developmental Strategies
- 19.15.7 SWOT Analysis
19.16 Abzena
- 19.16.1 Company Overview
- 19.16.2 Company Snapshot
- 19.16.3 Business Segments
- 19.16.4 Business Performance
- 19.16.5 Product Offerings
- 19.16.6 Key Developmental Strategies
- 19.16.7 SWOT Analysis
19.17 Rentschler Biopharma
- 19.17.1 Company Overview
- 19.17.2 Company Snapshot
- 19.17.3 Business Segments
- 19.17.4 Business Performance
- 19.17.5 Product Offerings
- 19.17.6 Key Developmental Strategies
- 19.17.7 SWOT Analysis
19.18 KBI Biopharma
- 19.18.1 Company Overview
- 19.18.2 Company Snapshot
- 19.18.3 Business Segments
- 19.18.4 Business Performance
- 19.18.5 Product Offerings
- 19.18.6 Key Developmental Strategies
- 19.18.7 SWOT Analysis
19.19 Cambrex
- 19.19.1 Company Overview
- 19.19.2 Company Snapshot
- 19.19.3 Business Segments
- 19.19.4 Business Performance
- 19.19.5 Product Offerings
- 19.19.6 Key Developmental Strategies
- 19.19.7 SWOT Analysis
19.20 Siegfried
- 19.20.1 Company Overview
- 19.20.2 Company Snapshot
- 19.20.3 Business Segments
- 19.20.4 Business Performance
- 19.20.5 Product Offerings
- 19.20.6 Key Developmental Strategies
- 19.20.7 SWOT Analysis

02-2729-4219

+886-2-2729-4219

License/价格

全球孤儿药 CDMO 市场分析与预测（至 2033 年）：类型、产品、服务、技术、应用、最终用户、阶段、流程、形式和组件

Orphan Drugs CDMO Market Analysis and Forecast to 2033: Type, Product, Services, Technology, Application, End User, Stage, Process, Mode, Component

目录

第 1 章 孤儿药 CDMO 市场概述

第 2 章 执行摘要

第3章 有关市场的重要考量因素

第4章 孤儿药CDMO市场展望

第 5 章：孤儿药 CDMO 市场策略

第 6 章：孤儿药 CDMO 市场规模

第 7 章 孤儿药 CDMO 市场按类型划分

第 8 章 孤儿药 CDMO 市场（依产品划分）

第 9 章 孤儿药 CDMO 市场（按服务）

第 10 章：孤儿药 CDMO 市场（按技术）

第 11 章：孤儿药 CDMO 市场（按应用）

第 12 章 孤儿药 CDMO 市场（依最终用户划分）

第 13 章：孤儿药 CDMO 市场（按阶段）

第 14 章 孤儿药 CDMO 市场（依流程）

第 15 章：孤儿药 CDMO 市场（按类型）

第 16 章 孤儿药 CDMO 市场（依组成部分）

第 17 章：孤儿药 CDMO 市场（按地区）

第18章 竞争格局

第19章 公司简介

Key Companies

Sources

Research Scope

TABLE OF CONTENTS

1: Orphan Drugs CDMO Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Orphan Drugs CDMO Market Outlook

5: Orphan Drugs CDMO Market Strategy

6: Orphan Drugs CDMO Market Size

7: Orphan Drugs CDMO Market, by Type

8: Orphan Drugs CDMO Market, by Product

9: Orphan Drugs CDMO Market, by Services

10: Orphan Drugs CDMO Market, by Technology

11: Orphan Drugs CDMO Market, by Application

12: Orphan Drugs CDMO Market, by End User

13: Orphan Drugs CDMO Market, by Stage

14: Orphan Drugs CDMO Market, by Process

15: Orphan Drugs CDMO Market, by Mode

16: Orphan Drugs CDMO Market, by Component

17: Orphan Drugs CDMO Market, by Region

18: Competitive Landscape

19: Company Profiles

第 1 章孤儿药 CDMO 市场概述

第 2 章执行摘要

第3章有关市场的重要考量因素

第4章孤儿药CDMO市场展望

第 7 章孤儿药 CDMO 市场按类型划分

第 8 章孤儿药 CDMO 市场（依产品划分）

第 9 章孤儿药 CDMO 市场（按服务）

第 12 章孤儿药 CDMO 市场（依最终用户划分）

第 14 章孤儿药 CDMO 市场（依流程）

第 16 章孤儿药 CDMO 市场（依组成部分）

第18章竞争格局

第19章公司简介